Why Is Archer Aviation Stock Going Up?
Archer Aviation (NYSE:ACHR) is an aviation startup that is working…
Buy
58
HERB Quote, Financials, Valuation and Earnings
Last price:
$0.0500
Seasonality move
:
3.16%
Day range:
$0.0210 - $0.0499
52-week range:
$0.0150 - $0.1450
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
0.04x
Volume:
11.3K
Avg. volume:
20.8K
1-year change:
-37.63%
Market cap:
$7.8M
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Yasheng Group has -- downside to fair value with a price target of -- per share.
HERB vs. S&P 500
-
Over the past 5 trading days, Yasheng Group has overperformed the S&P 500 by 60.02% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Yasheng Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Yasheng Group revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Yasheng Group reported revenues of --.
Earnings Growth
-
Yasheng Group earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Yasheng Group reported earnings per share of --.
Enterprise value:
52.1M
EV / Invested capital:
--
Price / LTM sales:
0.01x
EV / EBIT:
0.46x
EV / Revenue:
0.06x
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.16x
Price / Operating cash flow:
0.02x
Enterprise value / EBITDA:
0.40x
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2014-12-31 | 2015-12-31 | |
| Income Statement | ||||||
| Revenue | $1B | $1B | $938.9M | $303.6M | $229.3M | |
| Gross Profit | $143.5M | $142.9M | $119.2M | $50.6M | $25M | |
| Operating Income | $136.7M | $136.9M | $113.1M | $49.1M | $23.3M | |
| EBITDA | $150.5M | $151.6M | $129M | $51.2M | $27.2M | |
| Diluted EPS | $0.86 | $0.88 | $0.71 | $0.30 | $0.14 | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $235.9M | $334.1M | $437.8M | $469.8M | $118.2M | |
| Total Assets | $2.1B | $2.2B | $2.4B | $2.5B | $258.3M | |
| Current Liabilities | $62.2M | $41.1M | $44M | $37.2M | $99.4K | |
| Total Liabilities | $98.4M | $69.2M | $68.5M | $58.2M | $45.8M | |
| Total Equity | $2B | $2.1B | $2.3B | $2.4B | $212.6M | |
| Total Debt | $21.7M | $14.5M | $24.6M | $21.1M | $45.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2014-12-31 | 2015-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $51.1M | $68.1M | $321M | $24.8M | $278.3M | |
| Cash From Investing | -$43.8M | -$61.9M | -$324.3M | -$25M | -$285.9M | |
| Cash From Financing | -$8.4M | -$5.9M | $2.1M | -$1.8M | $4.8M | |
| Free Cash Flow | $51.1M | $68.1M | $321M | $24.8M | $278.3M | |
HERB
Sector
Market Cap
$7.8M
$244.4M
Price % of 52-Week High
34.41%
75%
Dividend Yield
0%
0%
Shareholder Yield
--
2.89%
1-Year Price Total Return
-37.63%
-10.63%
Beta (5-Year)
0.489
0.377
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.0306
200-day SMA
Sell
Level
$0.0568
Bollinger Bands (100)
Buy
Level
0.0312 - 0.0512
Chaikin Money Flow
Sell
Level
-594
20-day SMA
Buy
Level
$0.0342
Relative Strength Index (RSI14)
Buy
Level
63.4721
ADX Line
Buy
Level
15.4231
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$0.0343
MACD (12, 26)
Buy
Level
0.0088
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Sell
Level
-32K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HUMANOID INC, formerly Yasheng Group, is a Colorado corporation U.S. company, that conducts business operations in the U.S., China, Philippines through four segments: Mining, Agriculture and Biotechnology, and Blockchain+ IOT. The company's agricultural products include herbal medicine, herbal organic food, ginkgo, songaricum, betel nut, coconut, coffee, wolfberry, hemp, etc. It also designs, develops, and markets new technologies related to agriculture and genetic biology.
Stock Forecast FAQ
In the current month, HERB has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HERB average analyst price target in the past 3 months is --.
-
Where Will Yasheng Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Yasheng Group share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Yasheng Group?
Analysts are divided on their view about Yasheng Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Yasheng Group is a Sell and believe this share price will rise from its current level to --.
-
What Is Yasheng Group's Price Target?
The price target for Yasheng Group over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HERB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Yasheng Group is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HERB?
You can purchase shares of Yasheng Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Yasheng Group shares.
-
What Is The Yasheng Group Share Price Today?
Yasheng Group was last trading at $0.0500 per share. This represents the most recent stock quote for Yasheng Group. Yesterday, Yasheng Group closed at $0.0499 per share.
-
How To Buy Yasheng Group Stock Online?
In order to purchase Yasheng Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Brown Forman Stock Go?
On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…
Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
